We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current IMTX market cap is 830.34M. The company's latest EPS is EUR -1.2651 and P/E is -8.56.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 37.63M | 10.74M | 22.36M | 6.11M | 15.93M |
Operating Income | -11.08M | -26.43M | -14.31M | -37.3M | -27.71M |
Net Income | -13.23M | -19.75M | -24.61M | -26.49M | -26.15M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 18.83M | 31.56M | 35.09M | 172.86M | 55.14M |
Operating Income | -33.01M | -69.72M | -86.29M | 29.95M | -101.73M |
Net Income | -31.57M | -211.28M | -93.34M | 37.51M | -96.99M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 407.82M | 378.49M | 410.19M | 437.45M | 509.97M |
Total Liabilities | 194.66M | 178.4M | 191.98M | 189.7M | 284.88M |
Total Equity | 213.16M | 200.08M | 218.21M | 247.75M | 225.08M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 134.28M | 254.65M | 174.65M | 407.82M | 509.97M |
Total Liabilities | 175.11M | 167.26M | 150.58M | 194.66M | 284.88M |
Total Equity | -40.84M | 87.39M | 24.06M | 213.16M | 225.08M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | 100.13M | -23.72M | -30.32M | -60.85M | 18.23M |
Investing | -209.79M | -3.72M | -20.56M | -91.13M | -31.39M |
Financing | 123.71M | -866k | 35.59M | 85.49M | 84.52M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | 68.05M | -85.61M | -81.78M | 100.13M | 18.23M |
Investing | -2.14M | -15.95M | 7.49M | -209.79M | -31.39M |
Financing | -1.86M | 207.88M | -2.61M | 123.71M | 84.52M |
Market Cap | 830.34M |
Price to Earnings Ratio | -8.56 |
Price to Sales Ratio | 15.06 |
Price to Cash Ratio | 3.8 |
Price to Book Ratio | 3.69 |
Dividend Yield | - |
Shares Outstanding | 76.67M |
Average Volume (1 week) | 247.3k |
Average Volume (1 Month) | 327.18k |
52 Week Change | 10.85% |
52 Week High | 13.16 |
52 Week Low | 7.15 |
Spread (Intraday) | 1.03 (9.2%) |
Company Name | Immatics NV |
Address |
paul-ehrlich-street 15 tubingen 72076 |
Website | https://www.immatics.com |
Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions